During the past decade, University of Southern California Atherosclerosis Research Unit conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Southern California Atherosclerosis Research Unit" #1 collaborator was "National Institute on Aging (NIA)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University of Southern California Atherosclerosis Research Unit" are "Atherosclerosis" (1 trials), "Cognitive Decline" (1 trials), "Prevention of Cognitive Decline" (1 trials) and "Prevention of Subclinical Atherosclerosis Progression" (1 trials). Many other conditions were trialed in "University of Southern California Atherosclerosis Research Unit" in a lesser frequency.

Most popular intervention types in "University of Southern California Atherosclerosis Research Unit" are "Combination Product" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Nattokinase" (1 trials) and "Oral bazedoxifene 20 mg / conjugated estrogens 0.45 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Southern California Atherosclerosis Research Unit" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Southern California Atherosclerosis Research Unit". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in University of Southern California Atherosclerosis Research Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Southern California Atherosclerosis Research Unit, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".